295 related articles for article (PubMed ID: 17388944)
21. Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies.
Nakamura K; Mori F; Tanji K; Miki Y; Yamada M; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K
Neuropathology; 2015 Oct; 35(5):432-40. PubMed ID: 25950736
[TBL] [Abstract][Full Text] [Related]
22. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy.
Moors TE; Maat CA; Niedieker D; Mona D; Petersen D; Timmermans-Huisman E; Kole J; El-Mashtoly SF; Spycher L; Zago W; Barbour R; Mundigl O; Kaluza K; Huber S; Hug MN; Kremer T; Ritter M; Dziadek S; Geurts JJG; Gerwert K; Britschgi M; van de Berg WDJ
Acta Neuropathol; 2021 Sep; 142(3):423-448. PubMed ID: 34115198
[TBL] [Abstract][Full Text] [Related]
23. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.
Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N
Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370
[TBL] [Abstract][Full Text] [Related]
24. RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies.
Koss DJ; Bondarevaite O; Adams S; Leite M; Giorgini F; Attems J; Outeiro TF
Brain Pathol; 2021 Jan; 31(1):120-132. PubMed ID: 32762091
[TBL] [Abstract][Full Text] [Related]
25. Evidence in favor of Braak staging of Parkinson's disease.
Dickson DW; Uchikado H; Fujishiro H; Tsuboi Y
Mov Disord; 2010; 25 Suppl 1():S78-82. PubMed ID: 20187227
[TBL] [Abstract][Full Text] [Related]
26. [Lewy body formation in Parkinson's disease: neurodegeneration or neuroprotection?].
Wakabayashi K
Rinsho Shinkeigaku; 2008 Nov; 48(11):981-3. PubMed ID: 19198138
[TBL] [Abstract][Full Text] [Related]
27. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders.
Schmidt ML; Martin JA; Lee VM; Trojanowski JQ
Acta Neuropathol; 1996; 91(5):475-81. PubMed ID: 8740227
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
Kawamoto Y; Ito H; Ayaki T; Takahashi R
Brain Res; 2014 Jul; 1571():39-48. PubMed ID: 24835407
[TBL] [Abstract][Full Text] [Related]
29. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
30. Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies.
Katsuse O; Iseki E; Marui W; Kosaka K
J Neurol Sci; 2003 Jul; 211(1-2):29-35. PubMed ID: 12767494
[TBL] [Abstract][Full Text] [Related]
31. The Lewy body in Parkinson's disease and related neurodegenerative disorders.
Wakabayashi K; Tanji K; Odagiri S; Miki Y; Mori F; Takahashi H
Mol Neurobiol; 2013 Apr; 47(2):495-508. PubMed ID: 22622968
[TBL] [Abstract][Full Text] [Related]
32. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
[TBL] [Abstract][Full Text] [Related]
33. Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia.
Uchikado H; Iseki E; Tsuchiya K; Togo T; Katsuse O; Uéda K; Kato M; Kosaka K
Clin Neuropathol; 2002; 21(6):269-77. PubMed ID: 12489676
[TBL] [Abstract][Full Text] [Related]
34. Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification.
Hishikawa N; Hashizume Y; Ujihira N; Okada Y; Yoshida M; Sobue G
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):280-7. PubMed ID: 12787325
[TBL] [Abstract][Full Text] [Related]
35. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.
Lashuel HA
Neurobiol Dis; 2020 Jul; 141():104876. PubMed ID: 32339655
[TBL] [Abstract][Full Text] [Related]
36. Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.
Ruffmann C; Calboli FC; Bravi I; Gveric D; Curry LK; de Smith A; Pavlou S; Buxton JL; Blakemore AI; Takousis P; Molloy S; Piccini P; Dexter DT; Roncaroli F; Gentleman SM; Middleton LT
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):436-50. PubMed ID: 26527105
[TBL] [Abstract][Full Text] [Related]
37. Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies.
Togo T; Iseki E; Marui W; Akiyama H; Uéda K; Kosaka K
J Neurol Sci; 2001 Feb; 184(1):71-5. PubMed ID: 11231035
[TBL] [Abstract][Full Text] [Related]
38. HSP90 and Its Novel Co-Chaperones, SGT1 and CHP-1, in Brain of Patients with Parkinson's Disease and Dementia with Lewy Bodies.
Bohush A; Niewiadomska G; Weis S; Filipek A
J Parkinsons Dis; 2019; 9(1):97-107. PubMed ID: 30741686
[TBL] [Abstract][Full Text] [Related]
39. Defining a Lewy Body: Running Up the Hill of Shifting Definitions and Evolving Concepts.
Moors TE; Milovanovic D
J Parkinsons Dis; 2024; 14(1):17-33. PubMed ID: 38189713
[TBL] [Abstract][Full Text] [Related]
40. Lewy Bodies: A Spectator or Salient Killer?
Sian-Hulsmann J; Monoranu C; Strobel S; Riederer P
CNS Neurol Disord Drug Targets; 2015; 14(7):947-55. PubMed ID: 25801839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
